Loring Wolcott & Coolidge Fiduciary Advisors LLP Regeneron Pharmaceuticals, Inc. Transaction History

Loring Wolcott & Coolidge Fiduciary Advisors LLP

$10.4 Billion
Q1 2024

A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 87,274 shares of REGN stock, worth $92 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares

87,274

Previous 61,446 42.03%

Holding current value

$92 Million

Previous $54 Million 55.65%

% of portfolio

0.81%

Previous 0.55%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	BUY	$902.69 - $993.35 $23.3 Million - $25.7 Million	25,828 Added 42.03%	87,274 $84 Million
Q4 2023 Feb 01, 2024	BUY	$775.18 - $881.7 $13.6 Million - $15.5 Million	17,529 Added 39.91%	61,446 $54 Million
Q3 2023 Nov 03, 2023	BUY	$692.45 - $844.37 $18.8 Million - $23 Million	27,181 Added 162.41%	43,917 $36.1 Million
Q2 2023 Aug 01, 2023	BUY	$700.03 - $830.35 $2.81 Million - $3.33 Million	4,016 Added 31.57%	16,736 $12 Million
Q1 2023 May 02, 2023	BUY	$680.49 - $826.97 $83,700 - $101,717	123 Added 0.98%	12,720 $10.5 Million

Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $468,005 - $508,116	663 Added 5.56%	12,597 $9.2 Million
Q3 2022 Oct 25, 2022	BUY	$573.97 - $724.32 $533,218 - $672,893	929 Added 8.44%	11,934 $8.22 Million
Q2 2022 Jul 26, 2022	BUY	$548.35 - $738.84 $50,448 - $67,973	92 Added 0.84%	11,005 $6.51 Million
Q1 2022 Apr 13, 2022	BUY	$595.12 - $698.43 $42,253 - $49,588	71 Added 0.65%	10,913 $7.62 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $73,369 - $90,580	135 Added 1.26%	10,842 $6.85 Million
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $12,628 - $14,981	22 Added 0.21%	10,707 $6.48 Million
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $260,040 - $307,197	550 Added 5.43%	10,685 $5.97 Million
Q1 2021 Apr 14, 2021	BUY	$446.73 - $548.2 $4.46 Million - $5.47 Million	9,975 Added 6234.38%	10,135 $4.8 Million
Q4 2020 Jan 14, 2021	BUY	$478.3 - $607.98 $76,528 - $97,276	160 New	160 $77,000
Q2 2018 Aug 07, 2018	SELL	$284.6 - $344.99 $98,187 - $119,021	-345 Closed	0 $0
Q1 2018 Apr 20, 2018	SELL	$315.82 - $393.78 $126,328 - $157,512	-400 Reduced 53.69%	345 $119,000
Q3 2017 Oct 27, 2017	BUY	$431.38 - $504.0 $215,690 - $252,000	500 Added 204.08%	745 $333,000
Q2 2017 Aug 07, 2017	BUY	N/A	245	245 $0

Others Institutions Holding REGN

# of Institutions

1,429

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.

Account

Loring Wolcott & Coolidge Fiduciary Advisors LLP Regeneron Pharmaceuticals, Inc. Transaction History